Program
nacresertib
Also written as “Nacresertib”.
Its studies are led by AbbVie.
Furthest: phase 1, since Apr 29, 20263 company-led studies, 0 open or running
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| AbbVie | 30 open or running | phase 1since Apr 29, 2026 | Apr 29, 2026 | none ahead |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Apr 29, 2026First study: phase 1 study in Healthy VolunteersFirst studyNCT07566130 · 93 enrolled · United States
- May 14, 2026Phase 1 study in Healthy VolunteerNCT07600762 · 12 enrolled · United States
- Jun 11, 2026Phase 1 study in Healthy VolunteerNCT07649954 · 12 enrolled · United States
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 3 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07649954Healthy Volunteer · United States | 1 | Completed | Oct 5, 2026 | 12 |
| NCT07600762Healthy Volunteer · United States | 1 | Completed | Jun 17, 2026 | 12 |
| NCT07566130Healthy Volunteers · United States | 1 | Completed | May 7, 2026 | 93 |
How it is read
Names in the registry
- “Nacresertib”, 2 entries
- “nacresertib”, 1 entry
Conditions, from the studies’ own filings
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.